DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type i inhibitor camptothecin

Mutagenesis

Volumn 24, Issue 3, 2009, Pages 237-244

  Orta, Manuel Luís ^a   Mateos, Santiago ^a   Cortés, Felipe ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CAMPTOTHECIN; CYTIDINE; DNA TOPOISOMERASE; GENOMIC DNA;

ANIMAL CELL; ARTICLE; CHO CELL; COMPLEX FORMATION; CONTROLLED STUDY; DNA CLEAVAGE; DNA DEMETHYLATION; DNA FRAGMENTATION; DNA HYPOMETHYLATION; DNA METHYLATION; DNA PROTEIN COMPLEX; DNA STRAND BREAKAGE; ENZYME ACTIVITY; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AZACITIDINE; CAMPTOTHECIN; CHO CELLS; COMET ASSAY; CRICETINAE; CRICETULUS; DNA BREAKS; DNA METHYLATION; DNA TOPOISOMERASES, TYPE I; ELECTROPHORESIS, GEL, PULSED-FIELD; ENZYME INHIBITORS; EPIGENESIS, GENETIC;

CRICETULUS GRISEUS; MAMMALIA;

EID: 66749121440     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gep002     Document Type: Article

References (47)

1. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E. and Feinberg, A. P. (1993) Relaxation of imprinted genes in human cancer. Nature, 362, 747-751.
2. Bird, A. (1992) The essentials of DNA methylation. Cell, 70, 5-8.
3. Wang, J. C. (1996) DNA topoisomerases. Annu. Rev. Biochem., 65, 635-692.
4. Cortés, F., Pastor, N., Mateos, S. and Dominguez, I. (2007) Topoisom-erase inhibitors as therapeutic weapons. Expert Opin. Ther. Pat., 17, 521-532.
5. Thomsen, B., Mollerup, S., Bonven, B. J., Frank, R., Blöcker, H., Nielsen, O. F. and Westergaard, O. (1987) Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin. EMBO J., 6, 1817-1823.
6. Osheroff, N. (1989) Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol. Ther., 41, 223-241.
7. Capranico, G. and Binaschi, M. (1998) DNA sequence selectivity of topoisomerases and topoisomerase poisons. Biochim. Biophys. Acta, 1400, 185-194.
8. Muller, M. T. (1985) Quantitation of eukaryotic topoisomerase I reactivity with DNA. Preferential cleavage of supercoiled DNA. Biochim. Biophys. Acta, 20, 263-267.
9. Pourquier, P., Ueng, L.-M., Kohlhagen, G., Mazumder, A., Gupta, M., Kohn, K. W. and Pommier, Y. (1997) Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J. Biol. Chem., 272, 7792-7796.
10. Carrasco, C., Waring, M. J. and Bailly, C. (1998) Substitution of 5-methylcytosines for cytosines enhances the stability of topoisomerase I-DNA complexes and modulates the sequence selectivity of camptothecin-induced DNA cleavage. FEBS Lett., 425, 337-340.
11. Orta, M. L., Mateos, S., Cantero, G., Wolff, L. J. and Cortés, F. (2008) Protection of halogenated DNA from strand breakage and sister-chromatid exchange induced by the topoisomerase I inhibitor camptothecin. Mutat. Res., 637, 40-48.
12. Sambrook, J., Fritsch, E. F. and Maniatis, T. (2003) Gel electrophoresis of DNA. In: Irwin, N., Ford, N., Nolan, C. and Ferguson, M. (eds), Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
13. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
14. Muller, M. T. and Mehta, V. B. (1988) DNase I hypersensitivity is independent of endogenous topoisomerase II activity during chicken erythrocyte differentiation. Mol. Cell. Biol., 8, 3661-3669.
15. Subramanian, D., Kraut, E., Staubus, A., Young, D. C. and Muller, M. T. (1995) Analysis of topoisomerase I/DNA complexes in patients administered topothecan. Cancer Res., 55, 2097-2103.
16. Mateos, S., Domínguez, I., Pastor, N., Cantero, G. and Cortés, F. (2005) The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells. Mutat. Res., 578, 33-42.
17. Singh, N. P., McCoy, M. T., Tice, R. R. and Schneider, E. L. (1988) A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
18. Fairbairn, D. W., Olive, P. L. and O'Neill, K. L. (1995) The comet assay: a comprehensive review. Mutat. Res., 339, 37-59.
19. Olive, P. L., Banath, J. P. and Durand, R. E. (1990) Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J. Natl Cancer Inst., 82, 779-783.
20. Jones, P. A. and Taylor, S. M. (1980) Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20, 85-93.
21. Burdon, R. H., Quershi, M. and Adams, R. L. P. (1985) Nuclear matrix associated DNA methylase. Biochim. Biophys. Acta, 825, 70-79.
22. Hori, T. A. (1983) Induction of chromosome decondensation, sister-chromatid exchanges and endoreduplications by 5-azacytidine, an inhibitor of DNA methylation. Mutat. Res., 121, 47-52.
23. Kirchner, S., Schiffmann, D. and Stopper, H. (1995) The influence of DNA methylation on topoisomerase II activity and its possible link with genome instability in different cell lines of the Syrian hamster. Toxicol. In Vitro, 9, 519-525.
24. Boos, G. and Stopper, H. (2001) DNA methylation influences the decatenation activity of topoisomerase II. Int. J. Biol. Macrom., 28, 103-106.
25. Cortés, F., Pastor, N., Mateos, S. and Dominguez, I. (2003) Roles of DNA topoisomerases in chromosome segregation and mitosis. Rev. Mutat. Res., 543, 59-66.
26. Leteurtre, F., Kohlhagen, G., Fesen, M. R., Tanizawa, A., Kohn, K. W. and Pommier, Y. (1994) Effects of DNA methylation on topoisomerase I and II cleavage activities. J. Biol. Chem., 269, 7893-7900.
27. Been, M. D., Burgess, R. R. and Champox, J. J. (1984) Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. Nucleic Acids Res., 12, 3097-3114.
28. Osheroff, N. (1989) Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol. Ther., 41, 223-241.
29. Edwards, K. A., Halligan, B. D., Davis, J. L., Nivera, N. D. and Liu, L. F. (1982) Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA. Nucleic Acids Res., 10, 2565-2576.
30. Bonven, B. J., Gocke, E. and Westergaard, O. (1985) A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena r-chromatin. Cell, 41, 541-551.
31. Leonhardt, H. and Cardoso, M. C. (2000) DNA methylation, nuclear structure, gene expression and cancer. J. Cell Biochem., 35 (Suppl.), 78-83.
32. Käs, E. and Laemli, U. K. (1992) In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J., 11, 705-716.
33. Kanai, Y. and Hirohashi, S. (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 28, 2434-2442.
34. Jones, P. A. (2002) DNA methylation and cancer. Oncogene, 21, 5358-5360.
35. Jones, P. A. and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
36. Ushijima, T. (2005) Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer, 5, 223-231.
37. Baylin, S. B. and Ohm, J. E. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer, 6, 107-116.
38. Szyf, M. (2006) Targeting DNA methylation in cancer. Bull. Cancer, 93, 961-972.
39. Yang, A. S., Doshi, K. D., Choi, S. W. et al. (2006) DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukaemia. Cancer Res., 66, 5495-5503.
40. Kishlinger, J. E. and Godley, L. A. (2007) The use of hypomethylating agents in the treatment of hematologic malignancies. Leuk. Lymphoma, 48, 1676-1695.
41. Goshal, K. and Bai, S. (2007) DNA methyltransferases as targets for cancer therapy. Drugs Today, 43, 395-422.
42. Quintás-Cardama, A., Tong, W., Kantarjian, H. et al. (2008) A phase II study of 5-azacytidine for patients with primary and post-essential thrombocythemia/polycytemia vera myelofibrosis. Leukemia, 22, 965-970.
43. Atallah, E. and Garcia-Manero, G. (2008) Treatment strategies in myelodysplastic syndromes. Cancer Invest., 26, 208-216.
44. Hsiang, Y. H., Hertzberg, R., Hecht, S. and Liu, L. F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260, 14873-14878.
45. Sriram, D., Yogeeswari, P., Thirumurugan, R. and Bal, T. R. (2005) Camptothecin and its analogues: a review on their chemotherapeutic potential. Nat. Prod. Res., 19, 393-412.
46. Thomas, C. J., Rahier, N. J. and Hecht, S. M. (2004) Camptothecin: current perspectives. Bioorg. Med. Chem., 12, 1585-1604.
47. Pommier, Y. (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer, 6, 789-802.